HLA-E and chronic myelogenous leukemia, BCR-ABL1 positive: However, although there is still controversy about using KIR haplotyping as a predictive parameter of CML remission outcome [17,77], the importance of this feature as a predictive biomarker was lower than that of the high levels of functional cytotoxic cells and the presence of HLA-E*0103.